Pharmacokinetics & Safety of AmBisome & DKF-5122

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02527928` - Cost-Effectiveness of Amphotericin B	N/A
Completed	`NCT02851680` - Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.	N/A
Completed	`NCT03572049` - Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole	Phase 2/Phase 3
Suspended	`NCT05534529` - Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age	Phase 1
Completed	`NCT04024995` - Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological Malignancies
Completed	`NCT00745992` - Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients
Completed	`NCT06413056` - Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection	Phase 4
Recruiting	`NCT05130723` - Pharmacokinetics of Fluconazole in Children (2-18 Years)
Recruiting	`NCT04157465` - Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients	N/A
Completed	`NCT04122560` - Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration	Phase 4
Completed	`NCT03262584` - Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
Completed	`NCT02678598` - A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections	N/A
Completed	`NCT05491733` - A Bioequivalence Study of APX001 High-load and Low-load Tablets	Phase 1
Not yet recruiting	`NCT06220370` - PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.
Completed	`NCT04777058` - Pharmacokinetics of Isavuconazole in Patients in the Intensive Care Unit
Recruiting	`NCT03583164` - Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options	Phase 2
Completed	`NCT03174457` - Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study
Completed	`NCT00750737` - Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)	Phase 3
Not yet recruiting	`NCT06346951` - Survey on the Current Status of IFD Diagnosis and Treatment by Intensive Care Physicians in Sichuan Province (IFS)
Recruiting	`NCT05750706` - Prospective Observational Study on Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

NCT number	NCT05749380
Study type	Interventional
Source	Dongkook Pharmaceutical Co., Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	September 7, 2020
Completion date	January 28, 2022

Pharmacokinetics and Safety of AmBisome and DKF-5122

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms